检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:董毅[1] 朱太岗[1] 李月红[1] 葛曦[1] 张飞虎[1] 汤继春[1]
机构地区:[1]皖北煤电集团总医院血液科,安徽省宿州市234011
出 处:《中华全科医学》2011年第12期1844-1845,1938,共3页Chinese Journal of General Practice
摘 要:目的比较细胞因子诱导的杀伤细胞(cytokine-induced killer cells,CIK)与树突状细胞(dendritic cells,DC)结合CIK细胞抗肿瘤效应。方法外周血单个核细胞诱导DC和CIK细胞,将DC与CIK共培养,以CIK细胞单独培养为对照。用MTT法测定杀伤活性,流式细胞术分析免疫表型,ELISA法测定干扰素-γ(IFN-γ)、白介素-12(IL-12)、肿瘤坏死因子-α(TNF-α)的水平。结果 DC-CIK细胞增殖能力明显高于CIK细胞(P<0.05),DC-CIK细胞共培养后,CD3+CD8+、CD3+CD56+细胞比率较相同条件下CIK细胞组显著增多(P<0.05),共培养3 d,DC-CIK细胞上清液中IL-12、IFN-γ、TNF-α水平均比CIK细胞单独培养的水平高(P<0.01),DC-CIK细胞对白血病细胞与淋巴瘤细胞的杀伤率显著高于CIK细胞(P<0.01)。结论 DC-CIK细胞比CIK细胞有更强的抗肿瘤效应。Objective To compare the anti-tumor immune response effect of cytokine-induced killer(CIK) cells and dendritic cell(DC)-CIK cells.Methods DC and CIK cells were induced from peripheral blood mononuclear cells.DC and CIK cells were co-cultured,while CIK cells were cultured alone as controls.The killing activity was detected by MTT assay;immunophenotype changes were analyzed by flow cytometry;the IL-12,IFN-γ and TNF-αlevels of the cultured supernatants were detected by ELISA kits.Results The proliferation capability of DC-CIK cells was significantly higher than that of CIK cells.Under the same condition,the ratio of double positive cells such as CD3+CD8+,CD3+CD56+ in CIK cells was significantly enhanced by co-cultured with DC cells.The levels of IL-12,IFN-γ and TNF-α in cultured supernatants of DC-CIK cells increased noticeably on day 3 as compared with CIK cells cultured alone.The activity of DC-CIK cells against leukemia cells were much higher than that of CIK cells and this effect showed a positive correlation with the effector-target ratio.Conclusion The activity of DC-CIK against anti-tumor cells is significantly higher than that of CIK cells.
关 键 词:树突状细胞 细胞因子诱导的杀伤细胞 免疫治疗
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.117